Sarda Proteins Limited Board to Consider Name Change to Onix Power and Key Appointments

Sarda Proteins Limited (SPL) has announced a crucial Board of Directors meeting scheduled for July 26, 2025, set to address several significant matters that could reshape the company's future. The meeting, to be held via video conferencing at 11:00 A.M., will deliberate on a series of important proposals that could potentially transform the company's identity and governance structure.

Proposed Name Change

One of the most notable items on the agenda is the proposal to change the company's name from Sarda Proteins Limited to Onix Power Limited. This potential rebranding suggests a possible shift in the company's focus or expansion into new business areas, although specific reasons for the name change have not been disclosed.

Executive Appointment

The board will consider the appointment of Ms. Rinkal Malviya as a Woman Director in an executive capacity. This move aligns with corporate governance norms that emphasize gender diversity in company leadership and could bring fresh perspectives to the company's executive team.

Registered Office Relocation

Another significant proposal on the table is the shifting of the company's registered office. While the new location has not been specified, such a move could have implications for the company's operations and administrative functions.

Governance and Shareholder Engagement

The meeting will also address key governance matters, including:

1. Approval of the notice for an Extra-Ordinary General Meeting (EGM) to be conducted through video conferencing.
2. Appointment of a scrutinizer for overseeing the voting process.
3. Selection of an e-voting agency to facilitate remote voting for shareholders.

These steps indicate the company's commitment to shareholder engagement and compliance with modern corporate governance practices.

Implications and Next Steps

The outcomes of this board meeting could have far-reaching effects on Sarda Proteins Limited's corporate identity, governance, and potentially its business direction. Shareholders and market observers will be keenly watching for the results of these deliberations and any subsequent announcements.

The company has duly informed the BSE Limited of this upcoming meeting, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The official communication was signed by Mr. Khilan H. Savaliya, Director of Sarda Proteins Limited.

As these proposals require shareholder approval, the company is expected to provide further details and rationale for these changes in the upcoming EGM notice. Stakeholders are advised to stay tuned for more information as it becomes available following the board meeting on July 26, 2025.